federal_register: 2012-24331
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| document_number | title | type | abstract | publication_date | pub_year | pub_month | html_url | pdf_url | agency_names | agency_ids | excerpts |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2012-24331 | New Animal Drugs; Butorphanol; Doxapram; Triamcinolone; Tylosin | Rule | The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect the withdrawal approval of a new animal drug application (NADA) and three abbreviated new animal drug applications (ANADAs) at the sponsors' request because the products are no longer manufactured or marketed. | 2012-10-03 | 2012 | 10 | https://www.federalregister.gov/documents/2012/10/03/2012-24331/new-animal-drugs-butorphanol-doxapram-triamcinolone-tylosin | https://www.govinfo.gov/content/pkg/FR-2012-10-03/pdf/2012-24331.pdf | Health and Human Services Department; Food and Drug Administration | 221,199 | The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect the withdrawal approval of a new animal drug application (NADA) and three abbreviated new animal drug applications (ANADAs) at the sponsors' request because the... |